Welcome to Qurient

Qurient is a spin-off biotechnology company from institute Pasteur Korea (IPK) dedicated to develop novel therapeutics against infectious disease and inflammation. Qurient  has exclusive right to use discovery research products (drug candidates) and resources at IPK including the PhenomicScreen. Simultaneously Qurient is searching for In-Licensing opportunities from external partners such as academia and biotech for aligned strategic indications.

Latest News